In a dynamic market, the challenge for many companies is to offer pharmaceutical products perfectly suited to customers with very specific needs. More than ever, it becomes imperative to benefit from having close relations with Physicians, Pharmacists and decision makers at leading Hospitals, Clinics and Insurance companies. We at Nexcure can help you achieve in securing and building upon this relationship and adding value to business. Nexcure’s objective is to License-In registered brands of reputed pharmaceutical companies in the Middle East region and foster these brands by putting in place sales and marketing strategies to commercialize and attain significant market share by deploying its own dedicated field force for promotion. Our team has excelled in representing multiple therapy areas, by delivering excellence through the effective execution of the tactical marketing strategies. Nexcure provides comprehensive, multidisciplinary, experienced-based solutions that drive increased value for our clients and follow a well-defined process for each of our service areas - in-license, out-license and acquisition and enrich their execution by leveraging the capabilities and experience of our professionals drawing on a wide range of regional knowledge and multicultural perspective in the process

Our management team has broad experience and a deep understanding of the pharmaceutical industry and is committed to operating with integrity and dedication to improve patient's lives by identifying, sourcing and commercializing products in focused therapeutic areas. Our team has a proven track record of successfully sourcing and commercializing therapeutics and patient programs resulting in better patient care. Our Team consists of accomplished professionals with experience spanning the critical functions of Sales, Marketing, Regulatory and Business Development. From sales and pricing to strategic and operational marketing along with regulatory and medical management disciplines, our team’s experience boasts strong domain expertise required to excel in the region. We have also successfully built a strong, well established local key stakeholder network and distribution channels for business to fast-track market entry.

The fast growing and lucrative Middle East market bolstered by a developing African market has drawn a lot of interest in the pharmaceutical industry in recent years. The AfME region’s pharma market is projected to reach $ 60 billion by 2025 with a CAGR of 10% representing tremendous growth potential. With an aim to provide world class healthcare facilities as well as timely deliveries of medical and pharmaceutical supplies for the well being of a growing population, governments in the region have laid down the foundation for a promising future of the healthcare industry. The continued pressure on the bio fuels which is the major source of income for most of the Middle East countries has also contributed to a growing demand for affordable healthcare. Other catalysts include higher life expectancy, predominance of lifestyle related diseases, increased healthcare consciousness and growth in per capital income.